Table 1.
Summary of INFLADEP design.
| Preselection | Enrolment visit D0 | Assessment visit D7 (± 5 days) | |
|---|---|---|---|
| Patient information | ✓ | ✓ | |
| Collection of informed consent | ✓ | ||
| Clinical examination1 – Validation of eligibility criteria | ✓ | ||
| Collection of blood samples2 | ✓ | ||
| MRI examination | ✓ | ||
| PET examination | ✓ | ||
| Questions about concomitant treatments | ✓ | ✓ | |
| Search for AE/SAE | ✓ | ✓ |
1
Clinical examination: discussion with doctor, MADRS, BAS, C-SSCR, MINI surveys.
2
To measure CRP levels in healthy volunteers and biological markers (TNF-alpha, IL-6), TSPO phenotype in all subjects, beta-HCG for women of childbearing age.